From January 1, 2022 to March 31, 2022, the company has repurchased 49,868 shares, representing 0.42% for KRW 4,745.81 million. With this, the company has completed the repurchase of 160,533 shares, representing 1.35% for KRW 19,650.63 million under the buyback announced on October 15, 2020.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
100,000 KRW | -0.50% | -3.01% | -23.61% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-23.61% | 933M | |
+17.99% | 43.07B | |
+19.55% | 15.19B | |
+19.53% | 14.44B | |
+57.51% | 13.12B | |
-0.05% | 6.79B | |
-10.73% | 6.79B | |
-8.87% | 5.73B | |
+12.55% | 5.52B | |
+4.00% | 4.73B |
- Stock Market
- Equities
- A185750 Stock
- News Chong Kun Dang Pharmaceutical Corp.
- Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 15, 2020.